These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8825618)

  • 1. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.
    Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
    Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L
    Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.
    Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L
    Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
    Rabehi L; Ferriere F; Saffar L; Gattegno L
    Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
    Haidar M; Seddiki N; Gluckman JC; Gattegno L
    Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages.
    Nguyen DG; Hildreth JE
    Eur J Immunol; 2003 Feb; 33(2):483-93. PubMed ID: 12645947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
    Corbeau P; Haran M; Binz H; Devaux C
    Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
    Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
    Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H
    J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.